U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07839767) titled 'Treatment Selection by 3D Bioprinting Liver Model to Prevent Liver Cancer Recurrence' on Dec. 12, 2025.
Brief Summary: This study is a feasibility study about a test on adjuvant therapy for patients in hepatocellular carcinoma (HCC) with a higher risk of tumour recurrence after liver resection or ablation. By collecting individual patient's liver and tumour tissue during surgical operation, 3D bioprinting technology will be adopted to construct patient-specific biomimetic liver models -'Liver-in-Cube', to test and identify the most effective adjuvant therapy for individual patients, thereby personalising treatment and improving tre...